Clinical Trial Update: CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia (FibroCann) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/phase 3 clinical trial investigating CBD/THC solution as a pharmacological strategy for fibromyalgia is underway, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• CBD/THC Solution

Snippet

Sponsor: FG Brasil LTDA | Conditions: Fibromyalgia | Phase 2, Phase 3 | Status: UNKNOWN